Health Service Board approves Blue Shield Medicare PPO for city retirees over UnitedHealthcare

The San Francisco Health Service Board voted 4–2 to approve the staff recommendation to add Blue Shield of California as the Medicare Advantage prescription drug passive PPO (MAPD PPO) plan for the 2025 plan year, replacing UnitedHealthcare for the city’s Medicare retiree coverage.

Supervisor Dorsey moved to accept the staff’s recommendation and Doctor Fiona Wilson seconded. In a roll call vote the board recorded Vice President Howe, Supervisor Dorsey, Commissioner Greg Sass and Doctor Fiona Wilson as voting yes; Commissioner Art Howard and Commissioner Claire Zavansky voted no. The motion passed, 4–2, and the board chair said that the next agenda item concerning UnitedHealthcare would be rendered null.

The vote came after more than 35 callers and roughly 30 in‑person speakers delivered brief public comments, and the clerk reported the board received more than 400 written emails by the deadline, the large majority opposing the staff recommendation. Commenters — including multiple retired city employees and leaders of the San Francisco firefighters’ associations — urged the board to retain UnitedHealthcare, citing concerns about continuity of care, access to UCSF and other local hospitals, and plan quality ratings.

Board members who supported the recommendation defended the RFP process as exhaustive and a fiduciary obligation to the trust’s finances. Supervisor Dorsey said the competitive bidding process produced a lower‑cost bid and that commissioners would need clear evidence that selecting Blue Shield would harm care delivery to change course. Commissioner Greg Sass, who said he and his spouse are UnitedHealthcare members, argued the RFP was fair and that cost differences fall largely to the city budget, not retirees’ premiums.

SFHSS staff told commissioners roughly 17,000 members are enrolled in the UnitedHealthcare plan and that about 1,000 additional covered lives in non‑Medicare split family plans could be affected by the transition. Staff said detailed demographic and scoring materials were posted with the meeting packet and that Aon’s chief actuary and the agency contracts manager were available to answer technical questions.

Several public commenters also raised a procedural objection, arguing that by the board’s governance rules a motion to reconsider must be made by a member who voted with the prevailing side at the original meeting; callers said reopening the prior decision was improper. Board members responded that turnover on the board can change who occupies seats and therefore affects who can move reconsideration; the board proceeded to vote after discussion.

The clerk summarized the outcome and the chair adjourned the meeting. The approval renders the UnitedHealthcare MAPD PPO continuation item moot for this meeting; the board did not take further action on that item before adjourning.

What happens next: The board’s approval puts the Blue Shield MAPD passive PPO on track for implementation for the 2025 plan year per the staff recommendation; staff and the board will need to manage the operational transition and enrollment communications for affected retirees.